XML 17 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Provident Financial Holdings, Inc. Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Treasury Stock
Accumulated Other Conprehensive Income, Net of Tax
Restricted Stock [Member]
Stock Compensation Plan [Member]
Stock Repurchased During Period, Shares             3,090  
Common Stock, Dividends, Per Share, Cash Paid $ 0.36              
Shares outstanding, beginning balance at Jun. 30, 2015   8,634,607            
Balances at beginning of period-Amount at Jun. 30, 2015 $ 141,137 $ 177 $ 88,893 $ 188,206 $ (136,470) $ 331    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 4,919     4,919        
Other comprehensive loss (69)         (69)    
Purchase of treasury stock - Shares   (520,224)            
Purchase of treasury stock - Amount (8,917)       (8,917)      
Exercise of stock options - Shares   77,500            
Exercise of stock options - Amount 569 $ (2) (567)          
Stock Issued During Period, Shares, Restricted Stock Award, Gross   10,000            
Stock Issued During Period, Value, Restricted Stock Award, Gross 0              
Amortization of restricted stock 446   446          
Stock options expense     212          
Tax benefit from non-qualified equity compensation 212              
Cash dividends (3,041)     (3,041)        
Shares outstanding, ending balance at Mar. 31, 2016   8,201,883            
Balances at end of period-Amount at Mar. 31, 2016 135,650 $ 179 90,512 190,084 (145,387) 262    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock or Unit Option Plan Expense $ (394)   (394)          
Stock Repurchased During Period, Shares             3,090 4,500
Common Stock, Dividends, Per Share, Cash Paid $ 0.12              
Shares outstanding, beginning balance at Dec. 31, 2015   8,345,723            
Balances at beginning of period-Amount at Dec. 31, 2015 $ 137,865 $ 178 89,604 189,590 (141,753) 246    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 1,494     1,494        
Other comprehensive loss 16         16    
Purchase of treasury stock - Shares   (208,840)            
Purchase of treasury stock - Amount (3,634)       (3,634)      
Exercise of stock options - Shares   57,500            
Exercise of stock options - Amount 421 $ (1) (420)          
Stock Issued During Period, Shares, Restricted Stock Award, Gross   7,500            
Amortization of restricted stock 152   152          
Stock options expense 139   139          
Tax benefit from non-qualified equity compensation 197   197          
Cash dividends (1,000)     (1,000)        
Shares outstanding, ending balance at Mar. 31, 2016   8,201,883            
Balances at end of period-Amount at Mar. 31, 2016 $ 135,650 $ 179 90,512 190,084 (145,387) 262    
Common Stock, Dividends, Per Share, Cash Paid $ 0.39              
Shares outstanding, beginning balance at Jun. 30, 2016 7,975,250 7,975,250            
Balances at beginning of period-Amount at Jun. 30, 2016 $ 133,451 $ 178 90,802 191,666 (149,508) 313    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 4,243     4,243        
Other comprehensive loss (65)         (65)    
Purchase of treasury stock - Shares   (261,453)            
Purchase of treasury stock - Amount (4,999)       (4,999)      
Exercise of stock options - Shares   84,000            
Exercise of stock options - Amount $ 809 $ (1) (808)          
Stock Issued During Period, Shares, Restricted Stock Award, Gross 87,750              
Amortization of restricted stock $ 634   634          
Awards of Restricted Stock 0   (214)   214      
Stock options expense     14          
Restricted Stock or Unit Expense 0              
Tax benefit from non-qualified equity compensation 14              
Cash dividends $ (3,093)     (3,093)        
Shares outstanding, ending balance at Mar. 31, 2017 7,885,547 7,885,547            
Balances at end of period-Amount at Mar. 31, 2017 $ 131,591 $ 179 92,775 192,816 (154,427) 248    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock Issued During Period, Value, Restricted Stock Award, Forfeitures 0   134   (134)      
Stock or Unit Option Plan Expense $ (597)   (597)          
Stock Repurchased During Period, Shares             25,598  
Common Stock, Dividends, Per Share, Cash Paid $ 0.13              
Shares outstanding, beginning balance at Dec. 31, 2016   7,915,116            
Balances at beginning of period-Amount at Dec. 31, 2016 $ 132,555 $ 179 92,215 192,699 (152,802) 264    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 1,145     1,145        
Other comprehensive loss (16)         (16)    
Purchase of treasury stock - Shares   (89,819)            
Purchase of treasury stock - Amount (1,678)       (1,678)      
Exercise of stock options - Shares   60,250            
Exercise of stock options - Amount 524 $ 0 (524)          
Amortization of restricted stock 139   139          
Awards of Restricted Stock 0   (53)   53      
Stock options expense 115   115          
Tax benefit from non-qualified equity compensation (165)   (165)          
Cash dividends $ (1,028)     (1,028)        
Shares outstanding, ending balance at Mar. 31, 2017 7,885,547 7,885,547            
Balances at end of period-Amount at Mar. 31, 2017 $ 131,591 $ 179 $ 92,775 $ 192,816 $ (154,427) $ 248